Viewpoint
State Mifepristone Regulation Following
JAMA 10.1001/jama.2025.19752October 27, 2025 at 11:00 AM EDT
This Viewpoint discusses the decision and what it could mean for other cases challenging medication abortion restrictions on preemption grounds.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.